How much is Kinaset Therapeutics worth in 2026?

Kinaset Therapeutics has a current valuation of N/A based on their Later Stage VC (Series B) round and secondary market data.

How much funding has Kinaset Therapeutics raised?

Kinaset Therapeutics has raised N/A in total funding across 1 funding rounds.

Kinaset Therapeutics

Drug Discovery

Kinaset Therapeutics valuation and funding history | Last updated: January 10, 2026 | 1 funding rounds

Current Valuation

N/A

As of January 10, 2026

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series B)

$103.0M

Last Funding

Jan 2026

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
January 10, 2026	Later Stage VC (Series B)	$103.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Kinaset Therapeutics is currently valued at N/A as of January 10, 2026.

Track Kinaset Therapeutics Valuation Updates

Get notified when Kinaset Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Kinaset Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Kinaset Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Kinaset Therapeutics Worth in 2026?

Kinaset Therapeutics is a leading private company in the Drug Discovery sector. Track Kinaset Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Kinaset Therapeutics Valuation is Determined

Private company valuations like Kinaset Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.